BIO Latin America: Eli Lilly criticises innovation bar

A counsel for pharmaceutical company Eli Lilly has said that recent court decisions, including Ariosa v Sequenom, will create a bar to innovation.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

BIO Latin America: GSK says companies must recognise first inventor

16 October 2015 A director of a research initiative pioneered by pharmaceutical company GSK has said that recognising the initial owner of intellectual property is at the heart of its priorities.

Americas

BIO Latin America: Brazil and US urged to solve biotech patent delay

15 October 2015 The US’s consul general in Rio de Janeiro has urged the US and Brazilian governments to work together to tackle the long delay in biotechnology-related patents being granted at Brazil’s intellectual property office.

More on this story

Americas

BIO Latin America: GSK says companies must recognise first inventor

16 October 2015 A director of a research initiative pioneered by pharmaceutical company GSK has said that recognising the initial owner of intellectual property is at the heart of its priorities.

Americas

BIO Latin America: Brazil and US urged to solve biotech patent delay

More on this story

Americas

BIO Latin America: GSK says companies must recognise first inventor

16 October 2015 A director of a research initiative pioneered by pharmaceutical company GSK has said that recognising the initial owner of intellectual property is at the heart of its priorities.

Americas

BIO Latin America: Brazil and US urged to solve biotech patent delay